Longitudinal Follow-Up of Retinopathy and Opticopathy After Treatment With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as 3, 6, 9 and 12 months after radiation using sonography funds photography, optical coherence tomography angiography, oximeter and microperimetry.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients with newly diagnosed uveal melanoma, who will be treated with hypofractionated stereotactic photon radiotherapy as part of clinical routine.
Locations
Other Locations
Austria
Department of Ophthalmology and Optometry, Medical University Vienna
RECRUITING
Vienna
Contact Information
Primary
Judith Kreminger, MD
judith.kreminger@meduniwien.ac.at
0043 1 40400 48470
Backup
Reinhard Told, MD, PhD
reinhard.told@meduniwien.ac.at
0043 1 40400 48470
Time Frame
Start Date: 2023-11-23
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 20
Treatments
Uveal Melanoma
Patients with newly diagnosed uveal melanoma, which will be treated with hypofractionated stereotactic photon radiotherapy as clinical routine.
Related Therapeutic Areas
Sponsors
Leads: Medical University of Vienna